Literature DB >> 20625773

Accurate and simple method for quantification of hepatic fat content using magnetic resonance imaging: a prospective study in biopsy-proven nonalcoholic fatty liver disease.

Tomoko Hatta1, Yasunari Fujinaga, Masumi Kadoya, Hitoshi Ueda, Hiroaki Murayama, Masahiro Kurozumi, Kazuhiko Ueda, Michiharu Komatsu, Tadanobu Nagaya, Satoru Joshita, Ryo Kodama, Eiji Tanaka, Tsuyoshi Uehara, Kenji Sano, Naoki Tanaka.   

Abstract

BACKGROUND: To assess the degree of hepatic fat content, simple and noninvasive methods with high objectivity and reproducibility are required. Magnetic resonance imaging (MRI) is one such candidate, although its accuracy remains unclear. We aimed to validate an MRI method for quantifying hepatic fat content by calibrating MRI reading with a phantom and comparing MRI measurements in human subjects with estimates of liver fat content in liver biopsy specimens.
METHODS: The MRI method was performed by a combination of MRI calibration using a phantom and double-echo chemical shift gradient-echo sequence (double-echo fast low-angle shot sequence) that has been widely used on a 1.5-T scanner. Liver fat content in patients with nonalcoholic fatty liver disease (NAFLD, n = 26) was derived from a calibration curve generated by scanning the phantom. Liver fat was also estimated by optical image analysis. The correlation between the MRI measurements and liver histology findings was examined prospectively.
RESULTS: Magnetic resonance imaging measurements showed a strong correlation with liver fat content estimated from the results of light microscopic examination (correlation coefficient 0.91, P < 0.001) regardless of the degree of hepatic steatosis. Moreover, the severity of lobular inflammation or fibrosis did not influence the MRI measurements.
CONCLUSIONS: This MRI method is simple and noninvasive, has excellent ability to quantify hepatic fat content even in NAFLD patients with mild steatosis or advanced fibrosis, and can be performed easily without special devices.

Entities:  

Mesh:

Year:  2010        PMID: 20625773     DOI: 10.1007/s00535-010-0277-6

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  34 in total

1.  Adrenal masses: quantification of fat content with double-echo chemical shift in-phase and opposed-phase FLASH MR images for differentiation of adrenal adenomas.

Authors:  T Namimoto; Y Yamashita; K Mitsuzaki; Y Nakayama; O Makita; M Kadota; M Takahashi
Journal:  Radiology       Date:  2001-03       Impact factor: 11.105

Review 2.  Nonalcoholic fatty liver disease.

Authors:  Jeanne M Clark; Frederick L Brancati; Anna Mae Diehl
Journal:  Gastroenterology       Date:  2002-05       Impact factor: 22.682

3.  Useful parameters for distinguishing nonalcoholic steatohepatitis with mild steatosis from cryptogenic chronic hepatitis in the Japanese population.

Authors:  Naoki Tanaka; Eiji Tanaka; Yo Sheena; Michiharu Komatsu; Wataru Okiyama; Noriko Misawa; Hidetomo Muto; Takeji Umemura; Tetsuya Ichijo; Akihiro Matsumoto; Kaname Yoshizawa; Akira Horiuchi; Kendo Kiyosawa
Journal:  Liver Int       Date:  2006-10       Impact factor: 5.828

Review 4.  Fat suppression in MR imaging: techniques and pitfalls.

Authors:  E M Delfaut; J Beltran; G Johnson; J Rousseau; X Marchandise; A Cotten
Journal:  Radiographics       Date:  1999 Mar-Apr       Impact factor: 5.333

5.  Non-invasive quantification of hepatic fat fraction by fast 1.0, 1.5 and 3.0 T MR imaging.

Authors:  Sebastian Schuchmann; Christiane Weigel; Lothar Albrecht; Michael Kirsch; Arne Lemke; Gerd Lorenz; Rolf Warzok; Norbert Hosten
Journal:  Eur J Radiol       Date:  2007-01-30       Impact factor: 3.528

6.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Authors:  E M Brunt; C G Janney; A M Di Bisceglie; B A Neuschwander-Tetri; B R Bacon
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

7.  Fatty infiltration of the liver: demonstration by proton spectroscopic imaging. Preliminary observations.

Authors:  J K Lee; W T Dixon; D Ling; R G Levitt; W A Murphy
Journal:  Radiology       Date:  1984-10       Impact factor: 11.105

8.  Fatty liver. Chemical shift phase-difference and suppression magnetic resonance imaging techniques in animals, phantoms, and humans.

Authors:  D G Mitchell; I Kim; T S Chang; S Vinitski; P M Consigny; S A Saponaro; S M Ehrlich; M D Rifkin; R Rubin
Journal:  Invest Radiol       Date:  1991-12       Impact factor: 6.016

9.  Decrease in accumulation of ultrasound contrast microbubbles in non-alcoholic steatohepatitis.

Authors:  Hiroko Iijima; Fuminori Moriyasu; Kaoru Tsuchiya; Shiro Suzuki; Masahiro Yoshida; Masafumi Shimizu; Shunichi Sasaki; Syuhei Nishiguchi; Shiro Maeyama
Journal:  Hepatol Res       Date:  2007-06-07       Impact factor: 4.288

10.  The prevalence and etiology of elevated aminotransferase levels in the United States.

Authors:  Jeanne M Clark; Frederick L Brancati; Anna Mae Diehl
Journal:  Am J Gastroenterol       Date:  2003-05       Impact factor: 10.864

View more
  16 in total

1.  Clinical characteristics of young-onset ischemic colitis.

Authors:  Takefumi Kimura; Akihiro Shinji; Akira Horiuchi; Naoki Tanaka; Tadanobu Nagaya; Takashi Shigeno; Naoshi Nakamura; Michiharu Komatsu; Takeji Umemura; Norikazu Arakura; Akihiro Matsumoto; Eiji Tanaka
Journal:  Dig Dis Sci       Date:  2012-03-01       Impact factor: 3.199

2.  Clinical characteristics of de novo nonalcoholic fatty liver disease following pancreaticoduodenectomy.

Authors:  Naoki Tanaka; Akira Horiuchi; Takahide Yokoyama; Gengo Kaneko; Naoto Horigome; Takahiro Yamaura; Tadanobu Nagaya; Michiharu Komatsu; Kenji Sano; Shin-Ichi Miyagawa; Toshifumi Aoyama; Eiji Tanaka
Journal:  J Gastroenterol       Date:  2011-01-26       Impact factor: 7.527

3.  In vivo and ex vivo measurements: noninvasive assessment of alcoholic fatty liver using 1H-MR spectroscopy.

Authors:  Daniel Keese; Hüdayi Korkusuz; Frank Huebner; Dmitry Namgaladze; Bahram Raschidi; Thomas J Vogl
Journal:  Diagn Interv Radiol       Date:  2016 Jan-Feb       Impact factor: 2.630

4.  Controlled attenuation parameter for non-invasive assessment of hepatic steatosis in Chinese patients.

Authors:  Feng Shen; Rui-Dan Zheng; Yu-Qiang Mi; Xiao-Ying Wang; Qin Pan; Guang-Yu Chen; Hai-Xia Cao; Ming-Li Chen; Liang Xu; Jian-Neng Chen; Yi Cao; Rui-Nan Zhang; Lei-Ming Xu; Jian-Gao Fan
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

Review 5.  Non-invasive methods for the diagnosis of nonalcoholic fatty liver disease.

Authors:  Marianthi Papagianni; Areti Sofogianni; Konstantinos Tziomalos
Journal:  World J Hepatol       Date:  2015-04-08

6.  Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease.

Authors:  Jeffrey B Schwimmer; Michael S Middleton; Cynthia Behling; Kimberly P Newton; Hannah I Awai; Melissa N Paiz; Jessica Lam; Jonathan C Hooker; Gavin Hamilton; John Fontanesi; Claude B Sirlin
Journal:  Hepatology       Date:  2015-02-05       Impact factor: 17.425

Review 7.  [Functional MR imaging of the liver].

Authors:  A Wibmer; R Nolz; M Trauner; A Ba-Ssalamah
Journal:  Radiologe       Date:  2015-12       Impact factor: 0.635

8.  Heterogeneous living donor hepatic fat distribution on MRI chemical shift imaging.

Authors:  YoungRok Choi; Jeong Min Lee; Nam-Joon Yi; Hyeyoung Kim; Min-Su Park; Geun Hong; Tae Yoo; Suk-Won Suh; Hae Won Lee; Kwang-Woong Lee; Kyung-Suk Suh
Journal:  Ann Surg Treat Res       Date:  2015-06-11       Impact factor: 1.859

Review 9.  Nonalcoholic fatty liver disease: Noninvasive methods of diagnosing hepatic steatosis.

Authors:  Rasha AlShaalan; Murad Aljiffry; Said Al-Busafi; Peter Metrakos; Mazen Hassanain
Journal:  Saudi J Gastroenterol       Date:  2015 Mar-Apr       Impact factor: 2.485

10.  Diagnostic performance of a rapid magnetic resonance imaging method of measuring hepatic steatosis.

Authors:  Michael J House; Eng K Gan; Leon A Adams; Oyekoya T Ayonrinde; Sander J Bangma; Prithi S Bhathal; John K Olynyk; Tim G St Pierre
Journal:  PLoS One       Date:  2013-03-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.